196 related articles for article (PubMed ID: 33307268)
1. Relationship Between Oral Contraceptives and the Risk of Gliomas and Meningiomas: A Dose-Response Meta-Analysis and Systematic Review.
Yang X; Liu F; Zheng J; Cheng W; Zhao C; Di J
World Neurosurg; 2021 Mar; 147():e148-e162. PubMed ID: 33307268
[TBL] [Abstract][Full Text] [Related]
2. Reproductive factors and exogenous hormone use in relation to risk of glioma and meningioma in a large European cohort study.
Michaud DS; Gallo V; Schlehofer B; Tjønneland A; Olsen A; Overvad K; Dahm CC; Kaaks R; Lukanova A; Boeing H; Schütze M; Trichopoulou A; Bamia C; Kyrozis A; Sacerdote C; Agnoli C; Palli D; Tumino R; Mattiello A; Bueno-de-Mesquita HB; Ros MM; Peeters PH; van Gils CH; Lund E; Bakken K; Gram IT; Barricarte A; Navarro C; Dorronsoro M; Sánchez MJ; Rodríguez L; Duell EJ; Hallmans G; Melin BS; Manjer J; Borgquist S; Khaw KT; Wareham N; Allen NE; Tsilidis KK; Romieu I; Rinaldi S; Vineis P; Riboli E
Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2562-9. PubMed ID: 20802020
[TBL] [Abstract][Full Text] [Related]
3. Risk of brain tumors associated with exposure to exogenous female sex hormones.
Wigertz A; Lönn S; Mathiesen T; Ahlbom A; Hall P; Feychting M;
Am J Epidemiol; 2006 Oct; 164(7):629-36. PubMed ID: 16835295
[TBL] [Abstract][Full Text] [Related]
4. Occupational exposure to pesticides and central nervous system tumors: results from the CERENAT case-control study.
Baldi I; De Graaf L; Bouvier G; Gruber A; Loiseau H; Meryet-Figuiere M; Rousseau S; Fabbro-Peray P; Lebailly P
Cancer Causes Control; 2021 Jul; 32(7):773-782. PubMed ID: 33876308
[TBL] [Abstract][Full Text] [Related]
5. Central nervous system tumours among users of vaginal oestradiol tablets: A nationwide population-based study.
Pourhadi N; Meaidi A; Friis S; Torp-Pedersen C; Mørch LS
Eur J Neurol; 2023 Sep; 30(9):2811-2820. PubMed ID: 37309803
[TBL] [Abstract][Full Text] [Related]
6. Obesity and Risk for Brain/CNS Tumors, Gliomas and Meningiomas: A Meta-Analysis.
Sergentanis TN; Tsivgoulis G; Perlepe C; Ntanasis-Stathopoulos I; Tzanninis IG; Sergentanis IN; Psaltopoulou T
PLoS One; 2015; 10(9):e0136974. PubMed ID: 26332834
[TBL] [Abstract][Full Text] [Related]
7. Atopy and risk of brain tumors: a meta-analysis.
Linos E; Raine T; Alonso A; Michaud D
J Natl Cancer Inst; 2007 Oct; 99(20):1544-50. PubMed ID: 17925535
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for gliomas and meningiomas in males in Los Angeles County.
Preston-Martin S; Mack W; Henderson BE
Cancer Res; 1989 Nov; 49(21):6137-43. PubMed ID: 2790826
[TBL] [Abstract][Full Text] [Related]
9. Cohort studies of association between self-reported allergic conditions, immune-related diagnoses and glioma and meningioma risk.
Schwartzbaum J; Jonsson F; Ahlbom A; Preston-Martin S; Lönn S; Söderberg KC; Feychting M
Int J Cancer; 2003 Sep; 106(3):423-8. PubMed ID: 12845684
[TBL] [Abstract][Full Text] [Related]
10. Reproductive factors and risk of primary brain tumors in women.
Anic GM; Madden MH; Nabors LB; Olson JJ; LaRocca RV; Thompson ZJ; Pamnani SJ; Forsyth PA; Thompson RC; Egan KM
J Neurooncol; 2014 Jun; 118(2):297-304. PubMed ID: 24700240
[TBL] [Abstract][Full Text] [Related]
11. Allergic conditions and risk of glioma and meningioma in the CERENAT case-control study.
Pouchieu C; Raherison C; Piel C; Migault L; Carles C; Fabbro-Perray P; Loiseau H; Guillamo JS; Lebailly P; Baldi I
J Neurooncol; 2018 Jun; 138(2):271-281. PubMed ID: 29500663
[TBL] [Abstract][Full Text] [Related]
12. Risk of brain tumours in relation to estimated RF dose from mobile phones: results from five Interphone countries.
Cardis E; Armstrong BK; Bowman JD; Giles GG; Hours M; Krewski D; McBride M; Parent ME; Sadetzki S; Woodward A; Brown J; Chetrit A; Figuerola J; Hoffmann C; Jarus-Hakak A; Montestruq L; Nadon L; Richardson L; Villegas R; Vrijheid M
Occup Environ Med; 2011 Sep; 68(9):631-40. PubMed ID: 21659469
[TBL] [Abstract][Full Text] [Related]
13. Hormone replacement therapy and risk of meningioma in women: a meta-analysis.
Fan ZX; Shen J; Wu YY; Yu H; Zhu Y; Zhan RY
Cancer Causes Control; 2013 Aug; 24(8):1517-25. PubMed ID: 23702884
[TBL] [Abstract][Full Text] [Related]
14. Occupation and risk of glioma, meningioma and acoustic neuroma: results from a German case-control study (interphone study group, Germany).
Samkange-Zeeb F; Schlehofer B; Schüz J; Schlaefer K; Berg-Beckhoff G; Wahrendorf J; Blettner M
Cancer Epidemiol; 2010 Feb; 34(1):55-61. PubMed ID: 20061201
[TBL] [Abstract][Full Text] [Related]
15. Cellular telephones and risk for brain tumors: a population-based, incident case-control study.
Christensen HC; Schüz J; Kosteljanetz M; Poulsen HS; Boice JD; McLaughlin JK; Johansen C
Neurology; 2005 Apr; 64(7):1189-95. PubMed ID: 15824345
[TBL] [Abstract][Full Text] [Related]
16. Update on the effect of exogenous hormone use on glioma risk in women: a meta-analysis of case-control and cohort studies.
Lan YL; Wang X; Lou JC; Ma BB; Xing JS; Zou S; Zhang B
J Neurooncol; 2018 Apr; 137(2):357-365. PubMed ID: 29277854
[TBL] [Abstract][Full Text] [Related]
17. Exogenous sex hormone use and risk of meningioma: a population-based case-control study in Finland.
Korhonen K; Raitanen J; Isola J; Haapasalo H; Salminen T; Auvinen A
Cancer Causes Control; 2010 Dec; 21(12):2149-56. PubMed ID: 20730482
[TBL] [Abstract][Full Text] [Related]
18. Analgesic use and the risk of primary adult brain tumor.
Egan KM; Nabors LB; Thompson ZJ; Rozmeski CM; Anic GA; Olson JJ; LaRocca RV; Chowdhary SA; Forsyth PA; Thompson RC
Eur J Epidemiol; 2016 Sep; 31(9):917-25. PubMed ID: 26894804
[TBL] [Abstract][Full Text] [Related]
19. Hormonal exposures and the risk of intracranial meningioma in women: a population-based case-control study.
Custer B; Longstreth WT; Phillips LE; Koepsell TD; Van Belle G
BMC Cancer; 2006 Jun; 6():152. PubMed ID: 16759391
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic radiological examinations and risk of intracranial tumours in adults-findings from the Interphone Study.
Auvinen A; Cardis E; Blettner M; Moissonnier M; Sadetzki S; Giles G; Johansen C; Swerdlow A; Cook A; Fleming S; Berg-Beckhoff G; Iavarone I; Parent ME; Woodward A; Tynes T; McBride M; Krewski D; Feychting M; Takebayashi T; Armstrong B; Hours M; Siemiatycki J; Lagorio S; Larsen SB; Schoemaker M; Klaeboe L; Lönn S; Schüz J;
Int J Epidemiol; 2022 May; 51(2):537-546. PubMed ID: 34648614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
